Skip to main content
HCA
NYSE Life Sciences

HCA Healthcare Prices $3 Billion Senior Notes Offering

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$448.7
Mkt Cap
$99.672B
52W Low
$321.39
52W High
$556.52
Market data snapshot near publication time

summarizeSummary

HCA Healthcare has priced its senior notes offering of up to $3 billion, finalizing the terms of the debt issuance. This follows the company's announcement yesterday of a proposed public offering of senior notes, which was preceded by an S-3ASR filing. The pricing confirms the execution of a significant financing event, impacting the company's capital structure. Proceeds are expected to be used for refinancing existing indebtedness and general corporate purposes. Traders will monitor the closing of the offering and any further details on the specific allocation of funds.

At the time of this announcement, HCA was trading at $448.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $99.7B. The 52-week trading range was $321.39 to $556.52. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed HCA - Latest Insights

HCA
Apr 28, 2026, 6:23 AM EDT
Source: Reuters
Importance Score:
7
HCA
Apr 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
HCA
Apr 27, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
HCA
Apr 27, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
7
HCA
Apr 24, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
HCA
Apr 24, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
HCA
Mar 13, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
8